SYNERGISTIC ACTIVITY OF DOXORUBICIN AND THE BISDIOXOPIPERAZINE (+)-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF 187) AGAINST THE MURINE SARCOMA S180 CELL-LINE

被引：0

作者：

WADLER, S ^{[1
]}

GREEN, MD ^{[1
]}

MUGGIA, FM ^{[1
]}

机构：

[1] NYU,SCH MED,DIV MED ONCOL,NEW YORK,NY 10016

来源：

CANCER RESEARCH | 1986年 / 46卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1176 / 1181

页数：6

共 33 条

[1] THE HYDROLYSIS ACTIVATION OF THE DOXORUBICIN CARDIOPROTECTIVE AGENT ICRF-187 ((+)-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE)
HASINOFF, BB
DRUG METABOLISM AND DISPOSITION, 1990, 18 (03) : 344 - 349
[2] IS ICRF-187 [(+)-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE] UNUSUALLY REACTIVE FOR AN IMIDE
SISCO, JM
STELLA, VJ
PHARMACEUTICAL RESEARCH, 1992, 9 (08) : 1076 - 1082
[3] LETHAL AND SUBLETHAL EFFECTS OF THE COMBINATION OF DOXORUBICIN AND THE BISDIOXOPIPERAZINE, (+)-1,2,-BIS (3-5-DIOXOPIPERAZINYL-1-YL) PROPANE (ICRF 187), ON MURINE SARCOMA S180 INVITRO
WADLER, S
GREEN, MD
BASCH, R
MUGGIA, FM
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (09) : 1495 - 1501
[4] REDUCTION OF CHRONIC DOXORUBICIN CARDIOTOXICITY IN DOGS BY PRETREATMENT WITH (+/-)-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF-187)
HERMAN, EH
FERRANS, VJ
CANCER RESEARCH, 1981, 41 (09) : 3436 - 3440
[5] Effects of doxorubicin (adriamycin) and [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)]propane (ICRF-187) on skeletal muscle protease activities
Zima, T
Tesar, V
Richardson, PJ
Mantle, D
Preedy, VR
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 171 (03) : 135 - 140
[6] BISDIOXOPIPERAZINE, (+)-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF-187), ENHANCES THE ANTIPROLIFERATIVE EFFECT OF CISPLATIN ON HUMAN OVARIAN-CANCER CELLS
SCAMBIA, G
DELLABITTA, R
PANICI, PB
DEVINCENZO, R
CONTU, G
ERCOLI, A
BONANNO, G
PIERELLI, L
MANCUSO, S
GYNECOLOGIC ONCOLOGY, 1995, 57 (01) : 16 - 22
[7] COMPARISON OF THE EFFECTIVENESS OF (+/-)-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF-187) AND N-ACETYLCYSTEINE IN PREVENTING CHRONIC DOXORUBICIN CARDIOTOXICITY IN BEAGLES
HERMAN, EH
FERRANS, VJ
MYERS, CE
VANVLEET, JF
CANCER RESEARCH, 1985, 45 (01) : 276 - 281
[8] EFFECTS OF ICRF-186 [(L)1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE] ON THE TOXICITY OF DOXORUBICIN IN SPONTANEOUSLY HYPERTENSIVE RATS
ZHANG, J
HERMAN, EH
FERRANS, VJ
TOXICOLOGY, 1994, 92 (1-3) : 179 - 192
[9] ROLE OF (+/-)-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF-187) IN MODULATING FREE-RADICAL SCAVENGING ENZYMES IN DOXORUBICIN-INDUCED CARDIOMYOPATHY
ALDERTON, P
GROSS, J
GREEN, MD
CANCER RESEARCH, 1990, 50 (16) : 5136 - 5142
[10] AMELIORATIVE EFFECTS OF ICRF-187 [(+)-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-1-YL)PROPANE] ON THE CARDIOTOXICITY INDUCED BY DOXORUBICIN OR BY ISOPROTERENOL IN THE MOUSE
FLANDINA, C
SANGUEDOLCE, R
RAUSA, L
DALESSANDRO, N
RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1990, 70 (03): : 259 - 272

← 1 2 3 4 →